Literature DB >> 10402447

Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation.

C S Rihal1, K Sutton-Tyrrell, P Guo, N M Keller, R Jandova, M A Sellers, H V Schaff, D R Holmes.   

Abstract

BACKGROUND: Risks of coronary artery bypass graft surgery (CABG) or percutaneous transluminal coronary angioplasty (PTCA) may be different in the presence of peripheral vascular disease (PVD). METHODS AND
RESULTS: We analyzed outcomes of 550 patients with PVD enrolled in the Bypass Angioplasty Revascularization Investigation randomized trial and registry. Compared with 1770 patients without PVD, those with PVD were older and had a greater prevalence of medical comorbid conditions. No significant differences in coronary anatomy or PTCA success rates were found. The risk of any major complication (death, myocardial infarction, stroke, coma, or emergency revascularization) after PTCA was significantly higher among patients with PVD (11.7% versus 7.8%, P=0.027). In multivariate analysis, this represented a 50% increase in the odds of having any major complication (multivariate odds ratio, 1.5; P=0. 032). Among patients undergoing CABG, the risk of major complications was found to be markedly higher for patients with PVD (12%) than those without (6.1%, P=0.003) even after controlling for baseline differences (multivariate odds ratio, 1.8; P=0.018). Major differences between the PTCA and CABG groups were related primarily to a higher risk of neurological complications in PVD patients who had CABG (multivariate odds ratio, 2.8; P<0.001).
CONCLUSIONS: We conclude that patients with PVD are at high risk for periprocedural complications after myocardial revascularization, in particular neurological events.

Entities:  

Mesh:

Year:  1999        PMID: 10402447     DOI: 10.1161/01.cir.100.2.171

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment.

Authors:  D Mukherjee; E J Topol; D J Moliterno; D M Brennan; K Ziada; L Cho; S R Steinhubl
Journal:  Heart       Date:  2005-04-21       Impact factor: 5.994

2.  Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry).

Authors:  Shailja V Parikh; Shoaib Saya; Punag Divanji; Subhash Banerjee; Faith Selzer; J Dawn Abbott; Srihari S Naidu; Robert L Wilensky; David P Faxon; Alice K Jacobs; Elizabeth M Holper
Journal:  Am J Cardiol       Date:  2011-01-20       Impact factor: 2.778

3.  Early neuropsychological dysfunction in elderly high-risk patients after on-pump and off-pump coronary bypass surgery.

Authors:  Tomoko Baba; Tomoko Goto; Kengo Maekawa; Asuka Ito; Atushi Yoshitake; Takaaki Koshiji
Journal:  J Anesth       Date:  2007-11-01       Impact factor: 2.078

4.  Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD).

Authors:  Vijay Nambi; Kay T Kimball; Paul F Bray; Angela L Bergeron; Shawna L Johnson; Joel D Morrisett; Changyi Chen; Peter H Lin; Alan B Lumsden; Christie M Ballantyne; Jing-Fei Dong
Journal:  Platelets       Date:  2009-05       Impact factor: 3.862

5.  Risk Factors for Acute Kidney Injury Following Cardiac Surgery and Performance of Leicester Score in a Spanish Cohort.

Authors:  Alícia Molina Andújar; Alvaro Lucas; Victor Joaquin Escudero; Irene Rovira; Purificación Matute; Cristina Ibañez; Miquel Blasco; Elena Sandoval; Jesús Ruiz; Marina Chorda Sánchez; Gaston J Piñeiro; Eduard Quintana; Esteban Poch
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.